Afeltra A - Search Results

1

Prostacyclin in sepsis: a systematic review.

Zardi EM, Zardi DM, Dobrina A, Afeltra A. Zardi EM, et al. Among authors: afeltra a. Prostaglandins Other Lipid Mediat. 2007 Feb;83(1-2):1-24. doi: 10.1016/j.prostaglandins.2006.12.004. Epub 2006 Dec 29. Prostaglandins Other Lipid Mediat. 2007. PMID: 17259068 Review.

2

Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs.

Zardi EM, Zardi DM, Cacciapaglia F, Dobrina A, Amoroso A, Picardi A, Afeltra A. Zardi EM, et al. Among authors: afeltra a. Int Immunopharmacol. 2005 Mar;5(3):437-59. doi: 10.1016/j.intimp.2004.10.016. Int Immunopharmacol. 2005. PMID: 15683843 Review.

3

Enhanced portal flow velocity and volume following Iloprost treatment.

Zardi EM, Picardi A, Ambrosino G, Fazio VM, Dobrina A, Afeltra A, Frego M. Zardi EM, et al. Among authors: afeltra a. Acta Biomed. 2003;74 Suppl 2:108-10. Acta Biomed. 2003. PMID: 15055047

4

Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications.

Zardi EM, Picardi A, Fazio VM, Ambrosino G, Dobrina A, Zullo M, Zennaro D, Afeltra A. Zardi EM, et al. Among authors: afeltra a. J Interferon Cytokine Res. 2004 May;24(5):297-300. doi: 10.1089/107999004323065084. J Interferon Cytokine Res. 2004. PMID: 15153313

5

Iloprost: an adjunctive approach to chronic viral hepatitis treatment.

Zardi EM, Vespasiani Gentilucci U, Picardi A, Ambrosino G, Fazio VM, Dobrina A, Afeltra A. Zardi EM, et al. Among authors: afeltra a. Med Hypotheses. 2005;64(1):46-52. doi: 10.1016/j.mehy.2004.05.017. Med Hypotheses. 2005. PMID: 15533610

6

Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis.

Zardi EM, Picardi A, Ambrosino G, Fazio VM, Dobrina A, Frego M, Afeltra A, Lumachi F. Zardi EM, et al. Among authors: afeltra a. In Vivo. 2006 May-Jun;20(3):377-80. In Vivo. 2006. PMID: 16724674 Free article.

7

Prostacyclin in liver disease: a potential therapeutic option.

Zardi EM, Dobrina A, Amoroso A, Afeltra A. Zardi EM, et al. Among authors: afeltra a. Expert Opin Biol Ther. 2007 Jun;7(6):785-90. doi: 10.1517/14712598.7.6.785. Expert Opin Biol Ther. 2007. PMID: 17555364 Review.

8

New therapeutic approaches to liver fibrosis: a practicable route?

Zardi EM, Dobrina A, Ambrosino G, Margiotta D, Polistina F, Afeltra A. Zardi EM, et al. Among authors: afeltra a. Curr Med Chem. 2008;15(16):1628-44. doi: 10.2174/092986708784911560. Curr Med Chem. 2008. PMID: 18673229 Review.

9

Endothelial dysfunction and vascular stiffness in systemic lupus erythematosus: Are they early markers of subclinical atherosclerosis?

Zardi EM, Afeltra A. Zardi EM, et al. Among authors: afeltra a. Autoimmun Rev. 2010 Aug;9(10):684-6. doi: 10.1016/j.autrev.2010.05.018. Epub 2010 May 26. Autoimmun Rev. 2010. PMID: 20553974 Review.

10

Treatment of cryptosporidiosis in immunocompromised hosts.

Zardi EM, Picardi A, Afeltra A. Zardi EM, et al. Among authors: afeltra a. Chemotherapy. 2005 Jul;51(4):193-6. doi: 10.1159/000086920. Epub 2005 Jul 6. Chemotherapy. 2005. PMID: 16006765 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters